A critical discovery in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This crucial cancer suppressor protein is frequently disabled in various kinds of tumors, leading https://mysocialport.com/story7499222/nanobodies-reactivate-the-p53-protein-new-potential-approach-for-cancer-management